These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 22267178)
1. Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients. Yang S; Chen J; Guo Y; Lin H; Zhang Z; Feng G; Hao Y; Cheng J; Liang P; Chen K; Wu H; Li Y Int J Oncol; 2012 May; 40(5):1590-600. PubMed ID: 22267178 [TBL] [Abstract][Full Text] [Related]
2. miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma. Zhao L; Tang M; Hu Z; Yan B; Pi W; Li Z; Zhang J; Zhang L; Jiang W; Li G; Qiu Y; Hu F; Liu F; Lu J; Chen X; Xiao L; Xu Z; Tao Y; Yang L; Bode AM; Dong Z; Zhou J; Fan J; Sun L; Cao Y Oncotarget; 2015 Jun; 6(18):15995-6018. PubMed ID: 26201446 [TBL] [Abstract][Full Text] [Related]
3. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma. Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284 [TBL] [Abstract][Full Text] [Related]
4. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells. Feng X; Lv W; Wang S; He Q Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969 [TBL] [Abstract][Full Text] [Related]
5. RNA-Seq analysis of peripheral blood mononuclear cells reveals unique transcriptional signatures associated with radiotherapy response of nasopharyngeal carcinoma and prognosis of head and neck cancer. Liu G; Zeng X; Wu B; Zhao J; Pan Y Cancer Biol Ther; 2020; 21(2):139-146. PubMed ID: 31698994 [TBL] [Abstract][Full Text] [Related]
6. Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs. Li K; Zhu X; Li L; Ning R; Liang Z; Zeng F; Su F; Huang S; Yang X; Qu S Sci Rep; 2020 Mar; 10(1):5161. PubMed ID: 32198434 [TBL] [Abstract][Full Text] [Related]
7. Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks. Guo Y; Zhu XD; Qu S; Li L; Su F; Li Y; Huang ST; Li DR Int J Oncol; 2012 Jan; 40(1):85-92. PubMed ID: 21874234 [TBL] [Abstract][Full Text] [Related]
8. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis. Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing. Li G; Liu Y; Liu C; Su Z; Ren S; Wang Y; Deng T; Huang D; Tian Y; Qiu Y BMC Cancer; 2016 Sep; 16(1):719. PubMed ID: 27599611 [TBL] [Abstract][Full Text] [Related]
11. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy. Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. Fang W; Li X; Jiang Q; Liu Z; Yang H; Wang S; Xie S; Liu Q; Liu T; Huang J; Xie W; Li Z; Zhao Y; Wang E; Marincola FM; Yao K J Transl Med; 2008 Jun; 6():32. PubMed ID: 18570662 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of long non-coding RNA in primary nasopharyngeal carcinoma by microarray. Yang QQ; Deng YF Histopathology; 2015 Jun; 66(7):1022-30. PubMed ID: 25406670 [TBL] [Abstract][Full Text] [Related]
14. microRNA expression profiling of nasopharyngeal carcinoma. Li T; Chen JX; Fu XP; Yang S; Zhang Z; Chen KhH; Li Y Oncol Rep; 2011 May; 25(5):1353-63. PubMed ID: 21373758 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma. Li S; Liu T; Mo W; Hou Q; Zhou Y; Liu M; He Z; Liu Z; Chen Q; Wang H; Guo X; Xia W; Zeng M; Zhao H Radiat Oncol; 2016 Sep; 11(1):121. PubMed ID: 27647315 [TBL] [Abstract][Full Text] [Related]
16. Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Wu P; Zhang H; Qi L; Tang Q; Tang Y; Xie Z; Lv Y; Zhao S; Jiang W Oncol Rep; 2012 Apr; 27(4):987-94. PubMed ID: 22160175 [TBL] [Abstract][Full Text] [Related]
17. Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy. Ren M; Wang Z; Gao G; Gu X; Wu L; Chen L Tumour Biol; 2016 Sep; 37(9):11825-11833. PubMed ID: 27048285 [TBL] [Abstract][Full Text] [Related]
18. An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma. Gong Z; Yang Q; Zeng Z; Zhang W; Li X; Zu X; Deng H; Chen P; Liao Q; Xiang B; Zhou M; Li X; Li Y; Xiong W; Li G Tumour Biol; 2016 Mar; 37(3):3683-95. PubMed ID: 26462838 [TBL] [Abstract][Full Text] [Related]
19. Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways. Pan Y; Zhang Q; Atsaves V; Yang H; Claret FX Oncogene; 2013 May; 32(22):2756-66. PubMed ID: 22797071 [TBL] [Abstract][Full Text] [Related]
20. Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation. Wang S; Zhang R; Claret FX; Yang H Mol Cancer Ther; 2014 Dec; 13(12):3163-74. PubMed ID: 25319395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]